• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从配药记录中构建药物治疗期会受到时间间隔的影响。

Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length.

机构信息

Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CA Utrecht, the Netherlands.

出版信息

J Clin Epidemiol. 2010 Apr;63(4):422-7. doi: 10.1016/j.jclinepi.2009.07.001. Epub 2009 Oct 31.

DOI:10.1016/j.jclinepi.2009.07.001
PMID:19880282
Abstract

OBJECTIVES

When constructing drug treatment episodes using drug-dispensing databases, duration and the number of prescriptions belonging to a single treatment episode need to be defined. We investigated how different methods used to construct antidepressant treatment episodes influence their median estimated length.

STUDY DESIGN AND SETTING

A follow-up study among adult antidepressant drug users, identified from the Dutch PHARMO RLS, starting selective serotonin reuptake inhibitor (SSRI) use in 2001 was conducted. The influence of varying lengths of the prescription overlap and the gap between prescriptions (number of days or percentage of prescription duration) on the median antidepressant treatment episode length were investigated.

RESULTS

Of the 16,053 SSRI starters, 65.1% were female and mean age was 45.7 (SD: 17.2) years. Median antidepressant treatment episode length doubled when the gap length was expanded from 0 to 10 days. For short gap lengths the episode interquartile range was 40% to 200% larger when overlap was accounted for and when percentage of prescription duration gap length was used.

CONCLUSION

Differences in median episode length exist between methods that account for or disregard prescription overlap. These differences are of importance for studies that focus on drug exposure-outcome relationships and could have consequences for epidemiological analysis.

摘要

目的

在使用药物配药数据库构建药物治疗期时,需要定义治疗期的持续时间和属于单个治疗期的处方数量。我们研究了使用不同方法构建抗抑郁治疗期如何影响其中位数估计长度。

研究设计和设置

对 2001 年开始使用选择性 5-羟色胺再摄取抑制剂 (SSRI) 的荷兰 PHARMO RLS 中的成年抗抑郁药物使用者进行了一项随访研究。研究了处方重叠的不同长度和处方之间的间隙(天数或处方持续时间的百分比)对中位数抗抑郁治疗期长度的影响。

结果

在 16053 名 SSRI 启动者中,65.1%为女性,平均年龄为 45.7(SD:17.2)岁。当间隙长度从 0 扩展到 10 天时,抗抑郁治疗期长度增加了一倍。对于较短的间隙长度,当考虑到处方重叠时,治疗期四分位间距增加了 40%至 200%,而当使用处方持续时间间隙长度的百分比时,治疗期四分位间距增加了 40%至 200%。

结论

在考虑或不考虑处方重叠的方法之间,中位数期长度存在差异。这些差异对于关注药物暴露-结果关系的研究很重要,并且可能对流行病学分析产生影响。

相似文献

1
Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length.从配药记录中构建药物治疗期会受到时间间隔的影响。
J Clin Epidemiol. 2010 Apr;63(4):422-7. doi: 10.1016/j.jclinepi.2009.07.001. Epub 2009 Oct 31.
2
[Antidepressants consumption in the global population in France].[法国全球人口中的抗抑郁药消费情况]
Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.
3
Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias.抗抑郁药物治疗的持续时间及其对复发风险的影响:不朽且被忽视的时间偏倚。
Am J Epidemiol. 2009 Aug 1;170(3):280-5. doi: 10.1093/aje/kwp142. Epub 2009 Jun 4.
4
[Guidelines and reality in practical use of and compliance to antidepressants in the treatment of depression: incidence survey in Lorraine and Champagne-Ardenne (France)].[抑郁症治疗中抗抑郁药实际使用及依从性的指南与现实情况:法国洛林和香槟-阿登大区的发病率调查]
Encephale. 2009 Feb;35(1):73-9. doi: 10.1016/j.encep.2007.12.010. Epub 2008 May 16.
5
Antidepressant dispensing trends in New Zealand between 2004 and 2007.2004 年至 2007 年期间新西兰抗抑郁药的配药趋势。
Aust N Z J Psychiatry. 2009 Dec;43(12):1131-40. doi: 10.3109/00048670903279879.
6
The association between patient-reported drug taking and gaps and overlaps in antidepressant drug dispensing.患者报告的药物使用与抗抑郁药配药的差距和重叠之间的关联。
Ann Pharmacother. 2010 Nov;44(11):1755-61. doi: 10.1345/aph.1P162. Epub 2010 Oct 12.
7
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.美国儿科自杀倾向数据宣传对医生执业模式的影响。
Arch Gen Psychiatry. 2007 Apr;64(4):466-72. doi: 10.1001/archpsyc.64.4.466.
8
Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates.药物依从性、首次发作持续时间、总持续时间及无治疗时间:以双膦酸盐为例
Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):69-75. doi: 10.1002/pds.1687.
9
Determinants of antidepressant treatment outcome.抗抑郁治疗效果的决定因素。
Am J Manag Care. 2000 Dec;6(12):1327-36.
10
Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network (PPRNet).基层医疗实践中的抑郁症诊断与抗抑郁药使用:来自实践伙伴研究网络(PPRNet)的一项研究。
J Fam Pract. 2000 Jan;49(1):68-72.

引用本文的文献

1
Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research Datalink.钠-葡萄糖协同转运蛋白2抑制剂与全因死亡率风险:一项基于英国临床实践研究数据链的人群队列研究
Open Heart. 2025 Aug 26;12(2):e003254. doi: 10.1136/openhrt-2025-003254.
2
Determining Drug Exposure Based on Medication Dispensing Data: A Validation Study of Vitamin K Antagonist Treatment Episodes Against INR Records.基于药物配药数据确定药物暴露:维生素K拮抗剂治疗疗程与国际标准化比值(INR)记录的验证研究
Pharmacoepidemiol Drug Saf. 2025 Jun;34(6):e70158. doi: 10.1002/pds.70158.
3
Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis.
高维数据中倾向和疾病风险评分估计的机器学习方法:模式模拟与真实世界数据队列分析
Front Pharmacol. 2024 Oct 28;15:1395707. doi: 10.3389/fphar.2024.1395707. eCollection 2024.
4
Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain.基于西班牙健康记录的药物比较,使用美洛昔康与使用麦角胺的粒细胞缺乏风险。
Eur J Clin Pharmacol. 2024 Oct;80(10):1503-1514. doi: 10.1007/s00228-024-03706-5. Epub 2024 Jun 22.
5
Use of electronic health record data to examine administrations of pro re nata analgesics during hip fracture post-acute care.利用电子健康记录数据检查髋部骨折后急性护理期间的按需镇痛剂给药。
Pharmacoepidemiol Drug Saf. 2024 Jun;33(6):e5846. doi: 10.1002/pds.5846.
6
Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom.老年人在复杂健康需求下开始使用抗高血压药物后发生不良事件的风险:英国的一项自身对照病例系列研究。
Age Ageing. 2023 Sep 1;52(9). doi: 10.1093/ageing/afad177.
7
Drug dosage modifications in 24 million in-patient prescriptions covering eight years: A Danish population-wide study of polypharmacy.涵盖八年的2400万份住院处方中的药物剂量调整:丹麦一项关于多重用药的全人群研究。
PLOS Digit Health. 2023 Sep 7;2(9):e0000336. doi: 10.1371/journal.pdig.0000336. eCollection 2023 Sep.
8
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.2018 年欧盟降低风险措施和修订妊娠预防计划对丙戊酸类药物使用和处方趋势的影响:一项中断时间序列研究。
Drug Saf. 2023 Jul;46(7):689-702. doi: 10.1007/s40264-023-01314-3. Epub 2023 Jun 9.
9
Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study.生活方式和社会经济地位对非甾体抗炎药使用与主要不良心血管事件之间关联的影响:病例交叉研究。
Drug Saf. 2023 Jun;46(6):533-543. doi: 10.1007/s40264-023-01298-0. Epub 2023 May 2.
10
Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.非维生素 K 拮抗剂口服抗凝剂在房颤患者中降低标签外剂量的安全性。
Br J Clin Pharmacol. 2023 Feb;89(2):751-761. doi: 10.1111/bcp.15534. Epub 2022 Oct 3.